Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Let FDA approve NPIs While I have grave concerns about regulatory capture during the drugs approvals process at the Federal ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

In 1976, the Eagles released the song, “Life in the Fast Lane,” as part of their iconic album, Hotel California. Approximately 16 years later, ...

As we enter the new year, all eyes are on the biotech companies awaiting key FDA decisions in January. In 2024, the FDA approved 50 ...

Capricor stock gains 8% upon completing the rolling submission of the BLA for its lead asset, deramiocel, to treat DMD cardiomyopathy in the United States.

Undeterred by last year’s rejection and the recent approval of a close rival from Pfizer, Novo Nordisk has pushed its ...

Halozyme's attempt to acquire Evotec was a bold move to diversify revenue, but was ultimately unsuccessful, impacting HALO's ...

As of October 1, 2024, the Association of American Feed Control Official's (AAFCO) Annual Official Publication is no longer definitive as to ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

Four months after its board of directors started the process of dissolving the company, Galera Therapeutics has a new life ...

The Percheron Therapeutics (ASX:PER) board of directors has written a letter to shareholders following failure of its phase 2b trial of lead candidate avicursen (ATL-1102) into non-ambulant (unable to ...